Figure 1From: Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study Kaplan–Meier plot of PFS among patients treated with lanreotide autogel (n = 27). Back to article page